Literature DB >> 15599659

In vitro activity of azithromycin and dirithromycin against axenic Entamoeba histolytica.

S Ranque1, B Molet, D Christmann, E Candolfi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15599659     DOI： 10.1007/s10096-004-1250-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  10 in total

1.  Amoebiasis.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1997-04-04

2.  Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica.

Authors:  N A Samarawickrema; D M Brown; J A Upcroft; N Thammapalerd; P Upcroft
Journal:  J Antimicrob Chemother       Date:  1997-12       Impact factor: 5.790

3.  A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba.

Authors:  L S Diamond; D R Harlow; C C Cunnick
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

4.  A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites.

Authors:  W Huber; J C Koella
Journal:  Acta Trop       Date:  1993-12       Impact factor: 3.112

5.  Efficacy of macrolides vs. metronidazole against Entamoeba histolytica clinical isolates.

Authors:  A Georgopoulos; K F Linnau; A Buxbaum; C Coste; M A Ramirez de Los Santos; A Shabpar; W Graninger
Journal:  Wien Klin Wochenschr       Date:  2001-08-16       Impact factor: 1.704

Review 6.  Multidrug resistance in the protozoan parasite Entamoeba histolytica.

Authors:  E Orozco; C López; C Gómez; D G Pérez; L Marchat; C Bañuelos; D M Delgadillo
Journal:  Parasitol Int       Date:  2002-12       Impact factor: 2.230

7.  Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii.

Authors:  F G Araujo; D R Guptill; J S Remington
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

8.  In vitro susceptibilities of Entamoeba histolytica to azithromycin, CP-63,956, erythromycin, and metronidazole.

Authors:  J I Ravdin; J Skilogiannis
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

9.  Susceptibility testing of Entamoeba histolytica.

Authors:  J R Cedeño; D J Krogstad
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

10.  Growth inhibition of axenic Entamoeba histolytica by tubercidin and ara-A.

Authors:  W B Eubank; R E Reeves
Journal:  Am J Trop Med Hyg       Date:  1981-07       Impact factor: 2.345
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.